Investment in an interventional medical device company focused on cardiovascular diseases. The company currently has two products in the pipeline: 1) coronary drug coated balloons (DCB); and 2) left atrial appendage (LAA) occluder. The company plans to expand its product portfolio via R&D and acquisition, aiming to become a leading interventional medical device company in China.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke. Founded by experienced healthcare leaders and clinical advisors, Imperative Care understands the vast and urgent needs in stroke. Our focus is on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery.
Investment in a medical device company primarily focused on neurovascular intervention in China. With the purpose of building a holistic treatment platform for stroke patients, the company has a broad pipeline portfolio covering neurovascular access, ischemic stroke and hemorrhagic stroke.